Guardant Health, Inc.
Cancer evolution detection and diagnostic
Last updated:
Abstract:
The present disclosure provides methods for determining a probability that after any of a number of therapeutic interventions, an initial state of a subject, such as somatic cell mutational status of a subject with cancer, will develop a subsequent state. Such probabilities can be used to inform a health care provider as to particular courses of treatment to maximize probability of a desired outcome for the subject.
Status:
Grant
Type:
Utility
Filling date:
3 Sep 2020
Issue date:
22 Mar 2022